CR1447 (4-hydroxytestosterone, 4-OHT) binds towards the androgen receptor and has antiproliferative activity in both ER-positive and ER-negative/AR-positive breasts malignancy cells in preclinical research. tumour development and were changed. Related adverse occasions were all quality 2 and included exhaustion, bone tissue and joint discomfort, stiffness, dry pores and skin and mouth area, nausea, sweating, urinary system… Continue reading CR1447 (4-hydroxytestosterone, 4-OHT) binds towards the androgen receptor and has antiproliferative